Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic identification of the FcδR complex: TRβV12-4 as the IgD-binding domain targeted for immunotherapy in rheumatoid arthritis.

Journal of advanced research·2026

Same author

Circadian clock genes: Potential therapeutic targets for autoimmune diseases.

Journal of autoimmunity·2025

Same author

Democratizing protein language model training, sharing and collaboration.

Nature biotechnology·2025

Same author

Solvation Structure and Interface Engineering Synergy in Low-Temperature Sodium-Ion Batteries: Advances and Prospects.

Nanomaterials (Basel, Switzerland)·2025

Same author

GRK2 activates TRAF2-NF-<i>κ</i>B signalling to promote hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis.

Acta pharmaceutica Sinica. B·2025

Same author

Discovery of Aloperine as a Potential Antineoplastic Agent for Cholangiocarcinoma Harboring Mutant IDH1.

International journal of molecular sciences·2024

Search research articles

Related Experiment Video

Updated: May 24, 2025

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

Paeoniflorin-6'-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in

Tian Tian¹, Mengzhu Wei¹, Yanling Guan¹

¹Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Center of Rheumatoid Arthritis of Anhui Medical University, Hefei 230032, China.

Cellular Signalling

|March 4, 2025

Summary

This summary is machine-generated.

Paeoniflorin-6'-O-benesulfonic acid (CP-25) targets elevated GRK2 in psoriasis. CP-25 reduces skin damage and inflammation by inhibiting the JAK1-STAT3 pathway, offering a potential new treatment for this chronic skin disease.

Keywords:

CP-25 GRK2 JAK1 Psoriasis

More Related Videos

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Published on: January 17, 2012

Related Experiment Videos

Last Updated: May 24, 2025

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Published on: January 17, 2012

Area of Science:

Dermatology
Immunology
Pharmacology

Background:

Psoriasis is a chronic inflammatory skin disease characterized by keratinocyte hyperproliferation.
Th17 cells and keratinocytes play key roles in psoriasis pathogenesis.
Paeoniflorin-6 -O-benesulfonic acid (CP-25) shows anti-inflammatory and immunomodulatory effects, but its role in psoriasis is unknown.

Purpose of the Study:

To investigate the role of G protein-coupled receptor kinase 2 (GRK2) in psoriasis development.
To evaluate the therapeutic potential of CP-25, a GRK2 inhibitor, for psoriasis treatment.

Main Methods:

Assessed GRK2 expression in psoriasis patient skin and imiquimod-induced mouse models.
Administered CP-25 to psoriasis model mice to assess its effects on skin damage and inflammation.
Investigated the molecular mechanism of CP-25 action, including GRK2 translocation and downstream signaling pathways.

Main Results:

GRK2 expression was significantly elevated in psoriasis patients and mouse models.
CP-25 treatment reduced skin damage and systemic inflammation in mice.
CP-25 inhibited GRK2 translocation, decreased GRK2/Gβγ colocalization, increased GRK2/JAK1 colocalization, and downregulated the JAK1-STAT3 pathway, reducing keratinocyte hyperproliferation.
Alanine 321 in GRK2 was identified as crucial for CP-25's inhibitory effect on GRK2 translocation.

Conclusions:

Elevated GRK2 expression is implicated in psoriasis pathogenesis.
CP-25 demonstrates therapeutic potential for psoriasis by targeting GRK2 and modulating the JAK1-STAT3 signaling pathway.
Targeting GRK2 with CP-25 represents a promising therapeutic strategy for psoriasis.